Correlation Between Broadleaf and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Broadleaf and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Broadleaf and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Broadleaf Co and Spyre Therapeutics, you can compare the effects of market volatilities on Broadleaf and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Broadleaf with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Broadleaf and Spyre Therapeutics.
Diversification Opportunities for Broadleaf and Spyre Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Broadleaf and Spyre is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Broadleaf Co and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Broadleaf is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Broadleaf Co are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Broadleaf i.e., Broadleaf and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Broadleaf and Spyre Therapeutics
Assuming the 90 days horizon Broadleaf Co is expected to generate 1.7 times more return on investment than Spyre Therapeutics. However, Broadleaf is 1.7 times more volatile than Spyre Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 309.00 in Broadleaf Co on November 2, 2024 and sell it today you would earn a total of 199.00 from holding Broadleaf Co or generate 64.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.04% |
| Values | Daily Returns |
Broadleaf Co vs. Spyre Therapeutics
Performance |
| Timeline |
| Broadleaf |
| Spyre Therapeutics |
Broadleaf and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Broadleaf and Spyre Therapeutics
The main advantage of trading using opposite Broadleaf and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Broadleaf position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Broadleaf vs. NextPlat Corp | Broadleaf vs. Liquid Avatar Technologies | Broadleaf vs. Wirecard AG | Broadleaf vs. Waldencast Acquisition Corp |
| Spyre Therapeutics vs. Uber Technologies | Spyre Therapeutics vs. Porvair plc | Spyre Therapeutics vs. CLPS Inc | Spyre Therapeutics vs. Wheels Up Experience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges |